Coenzyme Q10 + NADH
Coenzyme Q10 + NADH has been studied in 1 paper since 2014: 1 trial in people. The newest paper, Dec 18, 2014: “Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?”.
See all 2 papers on coenzyme Q10 + NADH
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country; 2 trials, none about aging.
“A significant improvement of fatigue showing a reduction in fatigue impact scale total score (p<0.05) was reported in treated group versus placebo.”
None of its findings points the other way.
- 1 lab in 1 country
- 2 trials, none about aging
- Funders: Fundació Institut de Recerca Hospital Universitari Vall d’Hebron and 1 more
- 3 of 3 findings with company ties
- 2 of 2 trials sponsored by its developers
- Human trial1
Studies in people
1 study gave coenzyme Q10 + NADH to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases fatigue impact scale total scorep<0.05 up: Increases NAD/NADH ratiop<0.001 down: Decreases lipid peroxidesp<0.05 | Randomized trial8 weeks | 73 peopleChronic fatigue syndrome | Antioxidants & redox signaling, Dec 18, 2014 |
What did studies of coenzyme Q10 + NADH find?
3Studies of coenzyme Q10 + NADH measured 3 outcomes: lipid peroxides, NAD/NADH ratio and fatigue impact scale total score.
Lipid peroxides
downin humans1
1 study
Lipid peroxides
downin humans1
Coenzyme Q10 + NADH decreases lipid peroxides in humans (chronic fatigue syndrome) (p<0.05).
“lipoperoxides (p<0.05) were significantly lower in blood mononuclear cells of the treated group.”
Human trialchronic fatigue syndromeoralblood mononuclear cellsCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73
Antioxidants & redox signaling
NAD/NADH ratio
upin humans1
1 study
NAD/NADH ratio
upin humans1
Coenzyme Q10 + NADH increases NAD/NADH ratio in humans (chronic fatigue syndrome) (p<0.001).
“NAD+/NADH (p<0.001), CoQ10 (p<0.05), ATP (p<0.05), and citrate synthase (p<0.05) were significantly higher”
Human trialchronic fatigue syndromeoralblood mononuclear cellsCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73
Antioxidants & redox signaling
Fatigue impact scale total score
downin humans1
1 study
Fatigue impact scale total score
downin humans1
Coenzyme Q10 + NADH decreases fatigue impact scale total score in humans (chronic fatigue syndrome) (p<0.05).
“A significant improvement of fatigue showing a reduction in fatigue impact scale total score (p<0.05) was reported in treated group versus placebo.”
Human trialchronic fatigue syndromeoralCoQ10 (200 mg/day) plus NADH (20 mg/day)8 weeksn = 73
Antioxidants & redox signaling